Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-15

FDA Approved: BREYNA — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Breyna, a generic budesonide/formoterol fumarate inhalation product from Mylan, as an original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BREYNA (BUDESONIDE AND FORMOTEROL FUMARATE)

Snippet

ORIG AP for BREYNA (BUDESONIDE AND FORMOTEROL FUMARATE)